Key result
Aminophylline at 30 and 100 µM reversibly inhibited inward rectifier potassium current by ~20% and 30% in healthy porcine and failing human cardiomyocytes.
Why the study?
Aminophylline may induce arrhythmias, but the underlying mechanism is not well understood, prompting investigation of whether its inhibitory effect on inward rectifier potassium current occurs under clinically relevant conditions.
Does aminophylline inhibit inward rectifier potassium current in healthy porcine and failing human cardiomyocytes?
Does aminophylline inhibit inward rectifier potassium current in healthy porcine and failing human cardiomyocytes?
Aminophylline at clinically relevant concentrations inhibits the inward rectifier potassium current (I K1) and prolongs action potential duration in ventricular myocytes, providing a potential mechanism for its proarrhythmic effects.
Aminophylline, a bronchodilator mainly used to treat severe asthma attacks, may induce arrhythmias. Unfortunately, the underlying mechanism is not well understood. We have recently described a significant, on average inhibitory effect of aminophylline on inward rectifier potassium current I K1 , known to substantially contribute to arrhythmogenesis, in rat ventricular myocytes at room temperature. This study was aimed to examine whether a similar effect may be observed under clinically relevant conditions. Experiments were performed using the whole cell patch clamp technique at 37°C on enzymatically isolated healthy porcine and failing human ventricular myocytes. The effect of clinically relevant concentrations of aminophylline (10–100 µM) on I K1 did not significantly differ in healthy porcine and failing human ventricular myocytes. I K1 was reversibly inhibited by ∼20 and 30 % in the presence of 30 and 100 µM aminophylline, respectively, at −110 mV; an analogical effect was observed at −50 mV. To separate the impact of I K1 changes on AP configuration, potentially interfering ionic currents were blocked (L-type calcium and delayed rectifier potassium currents). A significant prolongation of AP duration was observed in the presence of 100 µM aminophylline in porcine cardiomyocytes which well agreed with the effect of a specific I K1 inhibitor Ba 2 + (10 µM) and with the result of simulations using a porcine ventricular cell model. We conclude that the observed effect of aminophylline on healthy porcine and failing human I K1 might be involved in its proarrhythmic action. To fully understand the underlying mechanism, potential aminophylline impact on other ionic currents should be explored. • The bronchodilator aminophylline may induce arrhythmias. • The mechanism of the proarrhythmic action of aminophylline is not well understood. • Aminophylline interacts with I K1 channels causing their inhibition on average. • The effect was similar in healthy porcine and failing human cardiomyocytes. • The observed effect of aminophylline might be involved in its proarrhythmic action.
No takes yet. Share an insight, caveat, or question.
Bébarová et al. (2024) studied Healthy porcine and failing human ventricular myocytes. Aminophylline was evaluated on Inward rectifier potassium current (IK1) inhibition. Aminophylline at 30 and 100 µM reversibly inhibited inward rectifier potassium current by ~20% and 30% in healthy porcine and failing human cardiomyocytes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: